EX-10.1





 Exhibit 10.1 

EMPLOYMENT AGREEMENT 

This EMPLOYMENT AGREEMENT, is dated as of March 8, 2021 (this “Agreement”), by MRC Global, Inc., a Delaware
corporation (the “Company”), and Robert James Saltiel, Jr. (the “Executive”) to be effective as of March 15, 2021 (the “Effective Date”). 

WHEREAS, the Company desires to employ the Executive as President and Chief Executive Officer and to utilize his management services as
indicated herein, and the Executive has agreed to provide such management services to the Company; 
 WHEREAS, the Executive desires to
accept the Company’s offer of employment as set forth herein to be effective on the Effective Date; 
 WHEREAS, the Company and the
Executive desire to enter into this Agreement to be effective as of the Effective Date; 
 NOW, THEREFORE, in consideration of the mutual
covenants contained herein and other valid consideration, the sufficiency of which is acknowledged, the parties hereto agree as follows: 
  

	1.	 Employment 


  

	 	1.1.	 Term. The Company agrees to employ the Executive, and the Executive agrees to be employed by the
Company, in each case, pursuant to this Agreement, for a period commencing on the Effective Date and ending on the earlier of: 


  

	 	(i)	 the second anniversary of the Effective Date; and 



 

	 	(ii)	 the termination of the Executive’s employment in accordance with Section 3 (the
“Term”); 


 provided, that on the second anniversary of the Effective Date and each subsequent
anniversary of the Effective Date, the Term shall automatically be extended for one year unless 90 days’ written notice of non-renewal is given by the Executive or the Company to the other party. 

 

	 	1.2.	 Duties. During the Term, the Executive shall serve as President and Chief Executive Officer of the
Company and in such other positions as an officer or director of the Company or its affiliates as the Executive and the Board of Directors of the Company (the “Board”) shall mutually agree from time to time. In addition, the
Executive shall be nominated to serve as a member of the Board during the Term. The Executive shall perform such duties, functions and responsibilities commensurate with the Executive’s positions as the Board reasonably directs.



  

	 	1.3.	 Exclusivity. During the Term, the Executive shall devote his full time and attention to the business and
affairs of the Company, shall faithfully serve the Company and shall, in all material respects, conform to and comply with the lawful and reasonable directions and instructions that the Board gives him, consistent with Section 1.2. During the
Term, the Executive shall use his best efforts to promote and serve the interests of the Company and shall not engage in any other business activity, whether or not the activity shall be engaged in for pecuniary profit, except that the Executive
may: 


  













	 	(i)	 sit on one board or similar governing body of other another for-profit
company with the consent of the Governance Committee of the Board, which shall not be unreasonably withheld; 


  

	 	(ii)	 subject to Executive’s obligations in Section 5, participate in any company that manages investments
in which Executive or his family has an interest; and 


  

	 	(iii)	 participate in industry or charitable endeavors that either support the Company’s interests or otherwise
do not interfere with Executive’s duties pursuant to this Agreement. 


  

	2.	 Compensation 


  


	 	2.1.	 Salary. As compensation for the performance of the Executive’s services under this Agreement,
during the Term, the Company shall pay to the Executive a salary at an annual rate of $825,000 (the “Base Salary”), payable in installments in accordance with the Company’s standard payroll policies and prorated for a period of
service less than a year. The Board (or a committee of the Board) shall review the Executive’s Base Salary annually and may increase the Base Salary (but may not decrease it) in the discretion of the Board (or a committee of the Board), based
on competitive data and the Executive’s performance. No increase in the Base Salary shall limit or reduce any other right or obligation of the Executive under this Agreement and the Base Salary shall not be reduced at any time (including after
any increase). 


  

	 	2.2.	 Annual Bonus. Beginning with the fiscal year of the Company that commences on January 1, 2021, for
each completed fiscal year during the Term, the Executive shall be eligible to receive additional cash incentive compensation pursuant to the annual bonus plan of the Company in effect at the time (the “Annual Bonus”). The target
Annual Bonus shall be 100% of the Executive’s Base Salary as in effect at the beginning of the fiscal year for which the bonus may be earned with the actual Annual Bonus to be based upon such individual or Company performance criteria
established for such fiscal year by the Board in consultation with the Executive. The Board (or a committee of the Board) shall review the Executive’s Annual Bonus target percentage annually and may adjust the Annual Bonus target percentage
upward (but not downward) in the discretion of the Board (or a committee of the Board), based on competitive data and the Executive’s performance. The Executive shall be eligible to receive an Annual Bonus for 2021 based upon the terms and
conditions of the annual bonus program that were established previously for the 2021 calendar year with the payout (based on results against the performance criteria) on the 2021 Annual Bonus reduced by 50%. 



 

	 	2.3.	 Long-Term Incentive Plan Participation. Beginning with the fiscal year that commences on January 1,
2021, for each fiscal year during the Term, the Executive shall be eligible to receive long-term incentive compensation awards pursuant to the Company’s 2011 Omnibus Incentive Plan or any replacement or successor plan (the “Long-Term
Incentive Awards”) in such amounts as the Board (or a committee of the Board) determines in its discretion on terms and conditions (including time and performance based vesting conditions) that are generally applicable to other senior
executives of the Company; provided, that the mix of types of Long-Term Incentive Awards awarded to the Executive may differ from those awarded to other senior executives to address limitations on the amount and types of awards permitted by
the 2011 Omnibus Incentive Plan or any replacement or successor plan. The Executive acknowledges that the Executive will receive his Long-Term Incentive Award for the 2021 calendar year as of the Effective Date. 



  
 2 














	 	2.4.	 Employee Benefits. During the Term, the Executive shall be eligible to participate in such health and
other group insurance and employee benefit plans and programs of the Company and its U.S. affiliates as in effect from time to time on the same basis as other senior executives of the Company. 



 

	 	2.5.	 Vacation. During the Term, the Executive shall be entitled to 25 days per calendar year of paid
vacation. 


  

	 	2.6.	 Business Expenses. The Company shall pay or reimburse the Executive for all commercially reasonable
business out-of-pocket expenses that the Executive incurs during the Term in performing his duties under this Agreement upon presentation of documentation and in
accordance with the expense reimbursement policy of the Company generally applicable to all senior executives as in effect from time to time. 


  

	 	2.7.	 Retirement. If Executive remains employed by the Company on or after the fifth anniversary of the
Effective Date (the “Target Date”), the Company terminates Executive’s employment other than for Cause, death or Disability prior to the Target Date or the Executive terminates employment for Good Reason prior to the Target
Date, Executive shall be deemed “Retired” and to have satisfied any requirement that the Participant’s age plus years of service equal to at least 80 for the purposes of any equity award agreement granted pursuant to the
Company’s 2011 Omnibus Incentive Plan, as amended, including (without limitation) any Restricted Stock Agreement, Restricted Stock Unit Award Agreement, Performance Share Unit Award Agreement or Stock Option Agreement and Executive shall be
entitled to continued vesting pursuant to the retirement provisions of each such agreement and any requirement under the award agreement that Executive must remain employed with the Company for any period of time prior to such Retirement for the
award to vest shall be waived; provided, that in the case of any Performance Share Unit Award Agreement the amount payable under the award shall be prorated as provided in the provision concerning “Termination under an Employment
Agreement” set forth in Section 5.4 of the applicable Performance Share Unit Award Agreement (notwithstanding the provisions in the “Retirement” provision of the award set forth in Section 5.3) and in the case of any
Restricted Stock Unit Award Agreement the amount payable under the award shall be payable within 30 days following the date the award becomes vested. Notwithstanding the foregoing in this Section 2.7, Executive shall only be entitled to
the retirement treatment that this Section 2.7 provides if Executive meets the Company’s Equity Ownership Guidelines measured as of the Target Date; provided that this requirement only applies if Executive’s employment is not
otherwise terminated prior to the Target Date. 


  

	3.	 Termination of Employment 



 

	 	3.1.	 Generally. The Company may terminate the Executive’s employment for any reason during the Term, and
the Executive may voluntarily terminate his employment for any reason during the Term, in each case (other than a termination by the Company for Cause (defined below)) at any time upon not less than 30 days’ written notice to the other party.
Upon the termination of the Executive’s employment with the Company for any reason, the Executive shall be entitled to any portion of the Base Salary earned but unpaid through the date of




  
 3 














	 	
termination, any earned but unpaid Annual Bonus for completed fiscal years, any unreimbursed expenses in accordance with Section 2.6 and, to the extent not yet paid or provided, any other
amounts or benefits required to be paid or provided at such time under any plan, program, policy or practice or other contract or agreement of the Company and its affiliates through the date of termination of employment (collectively, the
“Accrued Amounts”). The Accrued Amounts will be paid within 30 days of the date of termination. 

  

	 	3.2.	 Certain Terminations 



 

	 	a)	 Termination by the Company other than for Cause, death or Disability; Termination by the Executive for Good
Reason. If the Executive’s employment is terminated during the Term by the Company other than for Cause, death or Disability (defined below), or by the Executive for Good Reason (defined below), the Executive shall be entitled to:



  

	 	(i)	 the Accrued Amounts, 



 

	 	(ii)	 a pro-rata bonus for the fiscal year of termination, based on actual
performance through the end of the applicable fiscal year and the number of days that have elapsed in the fiscal year through the date of termination (a “Pro-Rata Bonus”),



  

	 	(iii)	 payment of an amount equal to the sum of 1/12 of Base Salary and 1/12 of the target Annual Bonus (each in
effect on his date of termination) each month for 24 months following termination (the “Severance Payments”), and 


  

	 	(iv)	 continuation of medical, dental and vision benefits on the same terms as active senior executives
(“Medical Continuation”) for 24 months following termination. For the period of time during which the Executive is entitled to Medical Continuation under this Section 3.2(a)(iv) (or Section 3.2(c)(iii), if applicable), the
Executive shall timely pay the full cost of the benefits as determined under the then-current practices of the Company on a monthly basis, provided that the Company shall reimburse the Executive the amounts timely paid for the coverage. The
Company shall pay all reimbursements to the Executive as required under this Section 3.2(a)(iv) on a regular, periodic basis within 30 days after the reimbursable amounts are paid by the Executive; provided that, prior to any
reimbursement, the Company must possess the applicable and appropriate evidence of the reimbursable amount. Any reimbursements provided during one taxable year of the Executive shall not affect the expenses eligible for reimbursement in any other
taxable year of the Executive (with the exception of applicable lifetime maximums applicable to medical expenses or medical benefits described in Section 105(b) of the Internal Revenue Code of 1986, as amended (the “Code”) and
the right to reimbursement under this Section 3.2(a)(iv) shall not be subject to liquidation or exchange for another benefit or payment. Following the Medical Continuation period, Executive shall be eligible to elect COBRA payable at
Executive’s expense in accordance with the Company’s standard procedures. 



  
 4 













 If, the Executive does not receive the “retirement” treatment set forth in
Section 2.7, and prior to a Change in Control (defined below) or after the 24-month period following a Change in Control, the Executive’s employment is terminated during the Term by the Company other
than for Cause, death or Disability, or by the Executive for Good Reason, all outstanding options, restricted stock awards and other long-term equity awards will continue to vest for the next 24-month period
as if Executive remained an active employee. Effective as of the end of this 24-month period, any non-vested options will be immediately forfeited. 

Receipt of the Severance Payments, Medical Continuation and extended vesting period shall be conditioned on: 

 

	 	(x)	 the Executive’s continued compliance with his obligations under Section 5, and 



 

	 	(y)	 the Executive’s execution, delivery and non-revocation of an
effective, valid and enforceable general release of claims (the “Release”) in the form attached as Exhibit A within 45 days of the effective date of the Executive’s termination. 



If the Executive breaches any of the covenants set forth in Section 5, the Executive shall immediately return to the Company that portion
of the Severance Payments that have been paid to the Executive pursuant to this Section 3.2(a), the Medical Continuation (and the Medical Continuation period) shall immediately terminate and any options that became vested pursuant to this
Section 3.2(a) shall immediately terminate. Subject to Section 3.2(d) and the provision of a valid Release as required under this Section 3.2(a), the Company will commence paying or providing the Severance Payments (other than the Pro-Rata Bonus) and Medical Continuation on the 60th day following the effective date of Executive’s termination of employment. Executive shall forfeit any
and all payments, benefits and extended vesting rights payable or due under this Agreement if Executive does not provide the Company with an effective Release within 45 days of the effective date of the Executive’s termination or revokes any
such release provided. The Pro-Rata Bonus will be paid at the time the Company ordinarily pays incentive bonuses to its executives with respect to the fiscal year in which the termination occurs (but in no
case later than March 15 of the calendar year following the calendar year in which Executive’s termination of employment occurs). 
  

	 	b)	 Termination upon Death or Disability. If the Executive’s employment is terminated due to the
Executive’s death or Disability, the Executive (or the Executive’s estate, if applicable) will receive (i) the Accrued Amounts, and (ii) a Pro-Rata Bonus which will be paid at the time the
Company ordinarily pays incentive bonuses to its executives with respect to the fiscal year in which the termination occurs (but in no case later than March 15 of the calendar year following the calendar year in which Executive’s
termination of employment occurs). 


  

	 	c)	 Termination following a Change in Control. If, during the Term and within 24 months following a
Change in Control, the Executive’s employment is terminated by the Company other than for Cause, death or Disability, or by the Executive for Good Reason, the Executive shall be entitled to: 



 

	 	(i)	 the Accrued Amounts, 



 

	 	(ii)	 payment of an amount equal to the sum of 24 months’ of Base Salary, and two times the target Annual Bonus,
each in effect on his date of termination (the “Change in Control Severance Payments”), and 



  
 5 














	 	(iii)	 Medical Continuation for 24 months. Premiums for Medical Continuation shall be paid and reimbursed in
accordance with the provisions contained in Section 3.2(a)(iv). Following the Medical Continuation period, Executive shall be eligible to elect COBRA in accordance with the Company’s standard procedures. 



Receipt of the Change in Control Severance Payments and Medical Continuation shall be conditioned on the Executive’s execution, delivery
and non-revocation of an effective and valid Release in the form attached as Exhibit A within 45 days of Executive’s termination of employment. Subject to Section 3.2(d) and the provision of a valid
Release as required under this Section 3.2(c), the Company will pay the Change in Control Severance Payments in a single lump sum payment and commence providing Medical Continuation on the
60th day following the effective date of Executive’s termination of employment. Executive shall forfeit any and all payments and benefits payable under this Agreement if Executive does not
provide the Company with an effective Release within 45 days of the effective date of the Executive’s termination or revokes any such release provided. 
  

	 	d)	 Section 409A Specified Employee. Notwithstanding anything to the contrary contained
in this Agreement, if the Executive is a “specified employee” for purposes of Section 409A of the Code and regulations and other interpretive guidance issued under the Code (“Section 409A”), the
Company shall not commence payment of the Severance Payments or the Change in Control Severance Payments to the Executive until one day after the day which is six months after the Executive’s termination date (the “Delay
Period”), with the first payment equaling the total of all payments that would have been paid during the Delay Period but for the application of Section 409A to those payments. For purposes of this Agreement, the Executive’s
employment with the Company shall be considered to have terminated for purposes of any provision of this Agreement providing for the payment or provision of any amounts or benefits following a termination of employment when, and only if, the
Executive has incurred a “separation from service” with the Company and its controlled subsidiaries and affiliates within the meaning of Section 409A(a)(2)(A)(i) of the Code, and applicable administrative guidance issued under the
Code. 


  

	 	e)	 Exclusive Remedy. The foregoing payments upon termination of the Executive’s employment described
in Section 3.2 shall constitute the exclusive severance payments due the Executive upon a termination of his employment under this Agreement. 


  

	 	3.3.	 Resignation from All Positions. Upon the termination of the Executive’s employment with the Company
for any reason, the Executive shall be deemed to have resigned, as of the date of such termination, from all positions he then holds as an officer, director, employee and member of the Board (and any committee of the Board) and the board of
directors or similar governing positions (and any committees of those bodies) of any of the Company’s affiliates. 


  

	 	3.4.	 Cooperation. Following the termination of the Executive’s employment with the Company for any
reason, the Executive agrees to reasonably cooperate with the Company upon reasonable request of the Board and to be reasonably available to the Company with respect to matters arising out of the Executive’s services to the Company and its
subsidiaries and affiliates. The Company shall pay the Executive a reasonable fee for those services and promptly reimburse the Executive for expenses reasonably incurred in connection with those matters. 



  
 6 














	4.	 Section 280G. 



 

	 	(i)	 If the aggregate of all amounts and benefits due to the Executive under this Agreement and under all other
arrangements with the Company would, if received by the Executive in full and valued under Section 280G of the Code, constitute “parachute payments” as defined in and under Section 280G of the Code (collectively, “280G
Compensation”), and 


  

	 	(ii)	 if such aggregate would, if reduced by all federal, state and local taxes applicable thereto, including the
excise tax imposed pursuant to Section 4999 of the Code, be less than the amount the Executive would receive, after all taxes, if the Executive received aggregate 280G Compensation equal (as valued under Section 280G of the Code) to only
three times the Executive’s “base amount” as defined in and under Section 280G of the Code, less $1.00, 



then the 280G Compensation shall (to the extent that the reduction of the 280G Compensation can achieve the intended result) be reduced or
eliminated to the extent necessary so that the aggregate 280G Compensation received by the Executive will not constitute parachute payments. For the avoidance of doubt, to the extent reasonable value is attributed to Executive’s obligations
pursuant to Section 5.2 such that the value so attributed is not a parachute payment included in 280G Compensation, such value shall be so allocated. An independent auditor (the “Auditor”) that the Company pays shall make the
determinations with respect to this Section 4. The Auditor shall be the Company’s regular independent auditor unless the Executive reasonably objects to the use of that firm, in which event the Auditor will be a nationally recognized
United States public accounting firm that the parties choose. 
  

	5.	 Unauthorized Disclosure; Non-Competition; Non-Solicitation; Interference with Business Relationships; Proprietary Rights 


  

	 	5.1.	 Unauthorized Disclosure. The Executive agrees and understands that in the Executive’s position with
the Company, the Executive has been and will continue to be exposed to and has and will receive information relating to the confidential affairs of the Company and its affiliates, including technical information, intellectual property, business and
marketing plans, strategies, customer information, software, other information concerning the products, promotions, development, financing, expansion plans, business policies and practices of the Company and its affiliates and other forms of
information that the Company and its affiliates consider to be confidential or in the nature of trade secrets (including, ideas, research and development, know-how, formulas, technical data, designs, drawings,
specifications, customer and supplier lists, pricing and cost information and business and marketing plans and proposals) (collectively, the “Confidential Information”). “Confidential Information” does not include any
information that becomes generally available to the public other than as a result of the Executive’s public use, disclosure, or fault. The Executive agrees that at all times during the Executive’s employment with the Company and
thereafter, the Executive shall not disclose such Confidential Information, either directly or indirectly, to any person or entity other than in connection with the Executive’s employment with the Company without the prior written consent of
the Company and shall not use or attempt to use any such 



  
 7 














	 	
Confidential Information in any manner other than in connection with his employment with the Company, unless required by law to disclose the Confidential Information, in which case the Executive
shall provide the Company with written notice of the requirement as far in advance of the anticipated disclosure as possible. This confidentiality covenant has no temporal, geographical or territorial restriction. Upon termination of the
Executive’s employment with the Company, the Executive shall promptly supply to the Company all property, keys, notes, memoranda, writings, lists, files, reports, customer lists, correspondence, tapes, disks, cards, surveys, maps, logs,
machines, technical data and any other tangible product or document that has been produced by, received by or otherwise submitted to the Executive during the Executive’s employment with the Company, and any copies thereof in his (or capable of
being reduced to his) possession; provided, that the Executive may retain his full rolodex or similar address and telephone directories. 


 

	 	5.2.	 Non-Competition. By and in consideration of the Company entering
into this Agreement and the payments made and the benefits that this Agreement provides, and in further consideration of the Executive’s exposure to the Confidential Information of the Company and its affiliates, the Executive agrees that the
Executive shall not, during the Executive’s employment with the Company and for 24 months thereafter (the “Restriction Period”), directly or indirectly, own, manage, operate, join, control, be employed by, or participate in the
ownership, management, operation or control of, or be connected in any manner with, including, without limitation, holding any position as a stockholder, director, officer, consultant, independent contractor, employee, partner, or investor in, any
Restricted Enterprise (defined below); provided, that in no event shall ownership of one percent or less of the outstanding securities of any class of any issuer whose securities are registered under the Securities Exchange Act of 1934, as
amended, standing alone, be prohibited by this Section 5.2, so long as the Executive does not have, or exercise, any rights to manage or operate the business of the issuer other than rights as an equity or stock holder of the issuer.
“Restricted Enterprise” means any person or entity that is actively engaged in any geographic area in any business which is either: 


  

	 	(i)	 in competition with the business of the Company or any of its subsidiaries or affiliates or



  

	 	(ii)	 proposed to be conducted by the Company or any of its subsidiaries or affiliates in their respective business
plans as in effect at that time; 


 provided, that a Restricted Enterprise shall not include: 

 

	 	(x)	 an investment company, private equity company, hedge fund or similar investment vehicle that owns a Restricted
Enterprise among other investments if the Executive does not provide the Executive’s services to Restricted Enterprise during the Restriction Period even though the Executive is providing services to the investment company, private equity
company, hedge fund or similar investment vehicle, and the Executive does not own directly or indirectly more than 10% of the equity value of the Restricted Enterprise or make any other investment in the Restricted Enterprise; or



  

	 	(y)	 a professional or advisory services firm that provides services to a Restricted Enterprise (among other
clients) if the Executive does not provide Executive’s services to Restricted Enterprise during the Restriction Period even though Executive is providing services to other clients of the firm. 



  
 8 













 For the purposes of this Section 5.2, a person or entity shall only be in competition
with the business of the Company or any of its subsidiaries or affiliates if the person or entity has more than $50 million in revenue, or 20% or more of its revenue, in each case, in its last completed four quarters from business that is
competitive with the Company or any of its subsidiaries or affiliates.    Notwithstanding any other provision of this Section 5.2 to the contrary, the Executive will not create in a
“start-up” any business that competes with the business of the Company or any of its subsidiaries or affiliates. 

During the Restriction Period, upon request of the Company, the Executive shall notify the Company of the Executive’s then-current
employment status. To the extent that any equity award agreement provided to the Executive as of the Effective Date or in the future, provides a restriction on the Executive similar to the restrictions contained in this Section 5, the
provisions of this Section 5 shall apply to the award agreement (including Section 8 of the Performance Share Unit Award Agreement and Section 7 of the Restricted Stock Unit Award Agreements provided to the Executive on the Effective
Date) in lieu of the restrictions in the award agreement, mutatis mutandis, and this Section 5 shall so govern. 
  

	 	5.3.	 Non-Solicitation of Employees. During the Restriction Period,
the Executive shall not directly or indirectly contact, induce or solicit (or assist any person or entity to contact, induce or solicit) for employment any person who is an employee of the Company or any of its subsidiaries or affiliates.



  

	 	5.4.	 Interference with Business Relationships. During the Restriction Period (other than in connection with
carrying out his responsibilities for the Company and its affiliates), the Executive shall not directly or indirectly contact, induce or solicit (or assist any person or entity to contact, induce or solicit) any customer or client of the Company or
its subsidiaries or affiliates to terminate its relationship or otherwise cease doing business in whole or in part with the Company or its subsidiaries or affiliates, or directly or indirectly interfere with (or assist any person or entity to
interfere with) any material relationship between the Company or its subsidiaries or affiliates and any of its or their customers or clients so as to cause harm to the Company or its affiliates. 



 

	 	5.5.	 Extension of Restriction Period. The Restriction Period shall be tolled for any period during which the
Executive is in breach of any of Sections 5.2, 5.3 or 5.4. 


  

	 	5.6.	 Proprietary Rights. The Executive shall disclose promptly to the Company any and all inventions,
discoveries, and improvements (whether or not patentable or registrable under copyright or similar statutes), and all patentable or copyrightable works, initiated, conceived, discovered, reduced to practice, or made by him, either alone or in
conjunction with others, during the Executive’s employment with the Company and related to the business or activities of the Company and its affiliates (the “Developments”). Except to the extent any rights in any Developments
constitute a work made for hire under the U.S. Copyright Act, 17 U.S.C. § 101, et seq., that are owned ab initio by the Company or its applicable affiliate, the Executive assigns all of his right, title and
interest in all Developments (including all intellectual property rights therein) to the Company or its nominee without further compensation, including all rights or benefits therefor, including without limitation the right to sue and recover for
past and future infringement. The Executive acknowledges that any 



  
 9 














	 	
rights in any Developments constituting a work made for hire under the U.S. Copyright Act, 17 U.S.C. § 101, et seq., are owned upon creation by the Company or its applicable affiliate
as the Executive’s employer. Whenever requested to do so by the Company, the Executive shall execute any and all applications, assignments or other instruments which the Company shall deem necessary to apply for and obtain trademarks, patents
or copyrights of the United States or any foreign country or otherwise protect the interests of the Company and its affiliates therein. These obligations shall continue beyond the end of the Executive’s employment with the Company with respect
to inventions, discoveries, improvements or copyrightable works initiated, conceived or made by the Executive while employed by the Company, and shall be binding upon the Executive’s employers, assigns, executors, administrators and other legal
representatives. In connection with his execution of this Agreement, the Executive has informed the Company in writing of any interest in any inventions or intellectual property rights that he holds as of the date hereof as set forth on Exhibit B
(the “Existing Inventions”). Notwithstanding anything to the contrary in this Agreement, the Developments shall not include any Existing Inventions. If the Company is unable for any reason, after reasonable effort, to obtain the
Executive’s signature on any document needed in connection with the actions described in this Section 5.6, the Executive hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as the
Executive’s agent and attorney-in-fact to act for and on the Executive’s behalf to execute, verify and file any such documents and to do all other lawfully
permitted acts to further the purposes of this Section 5.6 with the same legal force and effect as if executed by the Executive. 

  

	 	5.7.	 Remedies. The Executive agrees that any breach of the terms of this Section 5 would result in
irreparable injury and damage to the Company for which the Company would have no adequate remedy at law. The Executive, therefore, also agrees that in the event of a breach of this Section 5 or any threat of such a breach, the Company shall be
entitled to an immediate injunction and restraining order to prevent the breach, threatened breach or continued breach by the Executive or any and all persons acting for or with the Executive, without having to prove damages, in addition to any
other remedies to which the Company may be entitled at law or in equity, in each case, without the necessity of posting a bond or other security with the applicable court or body. The terms of this Section 5.8 shall not prevent the Company from
pursuing any other available remedies for any breach or threatened breach of this Agreement, including, the recovery of damages from the Executive. The Executive and the Company further agree that the provisions of the covenants contained in this
Section 5 are reasonable and necessary to protect the businesses of the Company and its affiliates because of the Executive’s access to Confidential Information and his material participation in the operation of such businesses.



  

	6.	 Representation. The Executive and the Company each represents and warrants that: 



 

	 	a)	 he or it is not subject to any contract, arrangement, policy or understanding, or to any statute, governmental
rule or regulation, that in any way limits his or its ability to enter into and fully perform his or its obligations under this Agreement, and 


  

	 	b)	 he or it is not otherwise unable to enter into and fully perform his or its obligations under this Agreement.




  
 10 














	7.	 Non-Disparagement. From and after the Effective Date and
following termination of the Executive’s employment with the Company, the Executive agrees not to make any statement (other than statements made in connection with carrying out his responsibilities for the Company and its subsidiaries and
affiliates) that is intended to become public, or that should reasonably be expected to become public, and that criticizes, ridicules, disparages or is otherwise derogatory of the Company or any of its subsidiaries, affiliates, employees, officers,
directors or stockholders. The Company and its affiliates shall cause their officers and directors not to make any such statement regarding the Executive. 


  

	8.	 Withholding. The Company may withhold from any amounts payable under this Agreement such United States
federal, state, local or foreign taxes as shall be required to be withheld pursuant to any applicable law or regulation. The Executive shall be solely responsible for the payment of all taxes relating to the payment or provision of any amounts or
benefits under this Agreement. 


  

	9.	 Definitions. For purposes of this Agreement, the following capitalized terms shall have the following
meanings: 


  

	 	9.1.	 “Cause” means the Executive’s: 



 

	 	a)	 continuing failure, for more than ten days after the Company’s written notice to the Executive of the
failure, to perform such duties as the Company reasonably requests, 


  

	 	b)	 failure to observe material policies generally applicable to officers or employees of the Company unless the
failure is capable of being cured and is cured within ten days of the Executive receiving written notice of the failure, 


  

	 	c)	 failure to cooperate with any internal investigation of the Company or any of its affiliates;



  

	 	d)	 commission of any act of fraud, theft or financial dishonesty with respect to the Company or any of its
affiliates or indictment or conviction of any felony; or 


  

	 	e)	 material violation of the provisions of this Agreement unless the violation is capable of being cured and is
cured within ten days of the Executive receiving written notice of the violation; 


 provided that it shall not be
Cause if a failure in Sections 9.1(a), (b) or (c) is a result of the Executive’s Disability or a violation in Section 9.1(e) occurs because the Executive’s Disability frustrates the Executive’s ability to perform. 

 

	 	9.2.	 “Change in Control” means: 



 

	 	a)	 An acquisition (other than directly from the Company) of any voting securities of the Company (the
“Voting Securities”) by any “Person” (for purposes of this Section 9.2, as the term “person” is used for purposes of Section 13(d) or 14(d) of the Exchange Act), immediately after which such
Person has “Beneficial Ownership” (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of more than fifty percent of: 



 

	 	(i)	 the then-outstanding shares of common stock, par value $.01 per share, of the Company and any other securities
into which those shares are changed or for which those shares are exchanged (“Shares”) or 



  
 11 














	 	(ii)	 the combined voting power of the Company’s then-outstanding Voting Securities; 



provided, that in determining whether a Change in Control has occurred pursuant to this Section 9.2(a), the acquisition of Shares
or Voting Securities in a Non-Control Acquisition (defined below) shall not constitute a Change in Control. A “Non-Control Acquisition” means an
acquisition by: 
  

	 	(i)	 an employee benefit plan (or a trust forming a part thereof) maintained by: 



 

	 	(A)	 the Company or 


  

	 	(B)	 any corporation or other Person the majority of the voting power, voting equity securities or equity interest
of which is owned, directly or indirectly, by the Company 


 (for purposes of this definition, a
“Related Entity”), 
  

	 	(ii)	 the Company or any Related Entity, or 



 

	 	(iii)	 any Person in connection with a Non-Control Transaction (defined
below); or 


  

	 	b)	 The consummation of: 



 

	 	(i)	 A merger, consolidation or reorganization (x) with or into the Company or (y) in which securities of
the Company are issued (a “Merger”), unless the Merger is a “Non-Control Transaction.” 



A “Non-Control Transaction” means a Merger in which: 

 

	 	(A)	 the shareholders of the Company immediately before the Merger own directly or indirectly immediately following
the Merger at least a majority of the combined voting power of the outstanding voting securities of: 


  

	 	(I)	 the corporation resulting from the Merger (the “Surviving Corporation”), if there is no Person
that Beneficially Owns, directly or indirectly, 50% or more of the combined voting power of the then-outstanding voting securities of the Surviving Corporation (a “Parent Corporation”), or 



 

	 	(II)	 if there is one or more than one Parent Corporation, the ultimate Parent Corporation; 



 

	 	(B)	 the individuals who were members of the Board immediately prior to the execution of the agreement providing for
the Merger constitute at least a majority of the members of the board of directors of: 


  

	 	(I)	 the Surviving Corporation, if there is no Parent Corporation, or 



 

	 	(II)	 if there is one or more than one Parent Corporation, the ultimate Parent Corporation; and




  
 12 














	 	(C)	 no Person other than: 



 

	 	(I)	 the Company or another corporation that is a party to the agreement of Merger, 



 

	 	(II)	 any Related Entity, 


  


	 	(III)	 any employee benefit plan (or any trust forming a part thereof) that, immediately prior to the Merger, was
maintained by the Company or any Related Entity, or 


  

	 	(IV)	 any Person who, immediately prior to the Merger had Beneficial Ownership of 50% or more of the then outstanding
Shares or Voting Securities, 


 has Beneficial Ownership, directly or indirectly, of 50% or more of the combined voting
power of the outstanding voting securities or common stock of: 
  

	 	(x)	 the Surviving Corporation, if there is no Parent Corporation, or 



 

	 	(y)	 if there is one or more than one Parent Corporation, the ultimate Parent Corporation. 



 

	 	c)	 A complete liquidation or dissolution of the Company; or 



 

	 	d)	 The sale or other disposition of all or substantially all of the assets of the Company and its subsidiaries
taken as a whole to any Person (other than (x) a transfer to a Related Entity or (y) the distribution to the Company’s shareholders of the stock of a Related Entity or any other assets). 



Notwithstanding the foregoing, a Change in Control shall not be deemed to occur solely because any Person (the “Subject
Person”) acquired Beneficial Ownership of more than the permitted amount of the then outstanding Shares or Voting Securities as a result of the acquisition of Shares or Voting Securities by the Company which, by reducing the number of
Shares or Voting Securities then outstanding, increases the proportional number of shares Beneficially Owned by the Subject Persons; provided that if a Change in Control would occur (but for the operation of this sentence) as a result of the
acquisition of Shares or Voting Securities by the Company and, after such share acquisition by the Company, the Subject Person becomes the Beneficial Owner of any additional Shares or Voting Securities and such Beneficial Ownership increases the
percentage of the then outstanding Shares or Voting Securities Beneficially Owned by the Subject Person, then a Change in Control shall occur. 
  

	 	9.3.	 “Disability” means the Executive is entitled to receive long-term disability benefits under
the long-term disability plan of the Company or its affiliates in which Executive participates, or, if there is no such plan, the Executive’s inability, due to physical or mental ill health, to perform the essential functions of the
Executive’s job, with or without a reasonable accommodation, for 180 days during any 365 day period irrespective of whether such days are consecutive. For the purpose of any Long-Term Incentive Award, the foregoing definition of Disability in
this Section 9.3 shall apply in lieu of any definition of Disability in the award agreement or the 2011 Omnibus Incentive Plan, as amended. 



  
 13 














	 	9.4.	 Good Reason” means 



 

	 	a)	 a material and adverse change in the Executive’s duties or responsibilities; provided that a
separation of the role of Chairman of the Board from Executive’s duties or responsibilities shall not be a material and adverse change; 


  

	 	c)	 a reduction in the Executive’s Base Salary or target Annual Bonus percentage; 



 

	 	d)	 a failure during any one calendar year of the Company to grant the Executive Long-Term Incentive Awards in
stated value of at least 400% of Base Salary; provided that if the Company determines not to provide a grant to the Executive and his direct reports due to extenuating circumstances such as dramatic downturn in the Company’s share price,
a failure shall not have occurred; provided further, that beginning in 2022, if the Company grants to the Executive Long-Term Incentive Awards that are intended to cover annual grants for multiple years, the stated value of any such
multi-year grants shall be credited to the appropriate future years. For the purposes of this Section 9.4(d), stated value is determined at the date of grant of a Long-Term Incentive Award and, in the case of equity awards, the number of shares
or units to determine the stated value shall be done on a basis consistent with all other executives of the Company (such as the Company’s practice as of the Effective Date that utilizes a 20-day volume weighted average trading price to
determine the number of restricted stock or performance share units equal to that stated value or a Black-Scholes valuation to determine a number of stock options equal to that stated value); 



 

	 	e)	 breach by the Company of any material provision of this Agreement; or 



 

	 	f)	 relocation of Executive’s principal place of employment by more than 50 miles from Executive’s then
current principal place of employment; 


 provided, that the Executive must give notice of termination for Good
Reason within 60 days of the occurrence of the first event giving rise to Good Reason. 
  

	10.	 Miscellaneous. 



 

	 	10.1.	 Indemnification. The Company shall indemnify the Executive to the fullest extent provided under the
Company’s By-Laws. The Company shall also maintain director and officer liability insurance in such amounts and subject to such limitations as the Board shall, in good faith, deem appropriate for coverage
of directors and officers of the Company. 


  

	 	10.2.	 Amendments and Waivers. This Agreement and any of the provisions of this Agreement may be amended,
waived (either generally or in a particular instance and either retroactively or prospectively), modified or supplemented, in whole or in part, only by written agreement signed by the Executive and the Company (by an officer other than the
Executive); provided, that, the observance of any provision of this Agreement may be waived in writing by the party that will lose the benefit of such provision as a result of such waiver. The waiver by any party of a breach of any provision
of this Agreement shall not operate or be construed as a further or continuing waiver of the breach or as a waiver of any other or subsequent breach, 



  
 14 














	 	
except as otherwise explicitly provided for in the waiver. Except as otherwise expressly provided in this Agreement, no failure on the part of any party to exercise, and no delay in exercising,
any right, power or remedy hereunder, or otherwise available in respect thereof at law or in equity, shall operate as a waiver thereof, nor shall any single or partial exercise of such right, power or remedy by the party preclude any other or
further exercise thereof or the exercise of any other right, power or remedy. 

  

	 	10.3.	 Assignment; No Third-Party Beneficiaries. This Agreement, and the Executive’s rights and
obligations hereunder, may not be assigned by the Executive, and any purported assignment by the Executive in violation of this Agreement shall be null and void. Nothing in this Agreement shall confer upon any person not a party to this Agreement,
or the legal representatives of the person, any rights or remedies of any nature or kind whatsoever under or by reason of this Agreement. 


  

	 	10.4.	 Notices. Unless otherwise provided in this Agreement, all notices, requests, demands, claims and other
communications provided for under the terms of this Agreement shall be in writing. Any notice, request, demand, claim or other communication under this Agreement shall be sent by 



 

	 	a)	 personal delivery (including receipted courier service) or overnight delivery service, 



 

	 	b)	 registered or certified mail, return receipt requested, postage prepaid and addressed to the intended recipient
as set forth below or 


  

	 	c)	 e-mail delivery, with confirmation of receipt, to the Company’s
General Counsel: 


  

			
	If to the Company:	  	 MRC Global, Inc.
 Fulbright Tower

1301 McKinney Street, Suite 2300
 Houston, TX 77010

 
 Attention: General Counsel

e-mail: XXXXXX

		
	If to the Executive:	  	 c/o MRC Global Inc.
 1301 McKinney, Suite
2300
 Houston, TX 77010,
  

at his principal office at the Company (e-mail: XXXXXX (during the Term),

 
 and at all times to his principal residence and personal
e-mail as reflected in the records of the Company, which initially reflect the following:
  

XXXXXX
 XXXXXX

 
 e-mail: XXXXXX




  
 15 













 All such notices, requests, consents and other communications shall be deemed to have been
given when received. Either party may change its address to which notices, requests, demands, claims and other communications under this Agreement are to be delivered by giving the other parties notice in the manner then set forth. 

 

	 	10.5.	 Governing Law. This Agreement shall be construed and enforced in accordance with, and the rights and
obligations of the parties shall be governed by, the laws of the State of Texas, without giving effect to the conflicts of law principles thereof. 


  

	 	10.6.	 Severability. Whenever possible, each provision or portion of any provision of this Agreement, including
those contained in Section 5, will be interpreted in such manner as to be effective and valid under applicable law but the invalidity or unenforceability of any provision or portion of any provision of this Agreement in any jurisdiction shall
not affect the validity or enforceability of the remainder of this Agreement in that jurisdiction or the validity or enforceability of this Agreement, including that provision or portion of any provision, in any other jurisdiction. In addition,
should a court or arbitrator determine that any provision or portion of any provision of this Agreement, including those contained in Section 5, is not reasonable or valid, either in period of time, geographical area, or otherwise, the parties
hereto agree that such provision should be interpreted and enforced to the maximum extent which such court or arbitrator deems reasonable or valid. 


  

	 	10.7.	 Entire Agreement. From and after the Effective Date this Agreement shall constitute the entire agreement
between the parties hereto, and supersede all prior representations, agreements and understandings (including any prior course of dealings), both written and oral, between the parties hereto with respect to the subject matter hereof.



  

	 	10.8.	 Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be
deemed an original, but all such counterparts shall together constitute one and the same instrument. This Agreement may be delivered through the means of e-mail delivery of a portable document format (.pdf)
file of the signed Agreement. 


  

	 	10.9.	 Binding Effect. This Agreement shall inure to the benefit of and be binding on, the successors of each
of the parties, including, without limitation, the Executive’s heirs and the personal representatives of the Executive’s estate and any successor to all or substantially all of the business and/or assets of the Company.



  

	 	10.10.	 General Interpretive Principles. The name assigned this Agreement and headings of the sections,
paragraphs, subparagraphs, clauses and subclauses of this Agreement are for convenience of reference only and shall not in any way affect the meaning or interpretation of any of the provisions hereof. Words of inclusion shall not be construed as
terms of limitation herein, so that references to “include,” “includes” and “including” shall not be limiting and shall be regarded as references to non-exclusive and non-characterizing illustrations. In this Agreement, references to a “party” mean either of the Company or the Executive and to the “parties” mean both of them; references to a “person”
mean any individual, corporation, partnership, limited liability company, association, trust or other entity or organization, including a government or political subdivision or an agency or instrumentality thereof; references to “Sections”
mean the sections and subsections of this Agreement; references to “Exhibits” mean the exhibits to this Agreement; references to the singular include the plural and vice versa, in each case, unless the context expressly requires the
contrary. 



  
 16 














	 	10.11.	 Mitigation. Notwithstanding any other provision of this Agreement, 



 

	 	a)	 the Executive will have no obligation to mitigate damages for any breach or termination of this Agreement by
the Company, whether by seeking employment or otherwise and 


  

	 	b)	 the amount of any payment or benefit due the Executive after the date of such breach or termination will not be
reduced or offset by any payment or benefit that the Executive may receive from any other source. 


  

	 	10.12.	 Section 409A Compliance. This Agreement is intended to comply with Section 409A
(to the extent applicable) and, to the extent it would not adversely impact the Company, the Company agrees to interpret, apply and administer this Agreement in the least restrictive manner necessary to comply with such requirements and without
resulting in any diminution in the value of payments or benefits to the Executive. Each payment made under this Agreement will be treated as a separate payment and the right to a series of monthly payments under this Agreement will be treated as a
right to a series of separate and distinct payments. Notwithstanding anything herein to the contrary, this Agreement will be interpreted, operated and administered in a manner consistent with such intentions; provided, that in no event will
the Company or any affiliate be liable for any additional tax, interest or penalty that may be imposed on the Executive pursuant to Section 409A or for any damages incurred by the Executive as a result of this Agreement (or the payments or
benefits hereunder) failing to comply with, or be exempt from, Section 409A. 


 IN WITNESS WHEREOF, the parties have
executed this Agreement as of the date first written above. 
  

			
	MRC GLOBAL, INC.
		
	By:	 	 /s/ Rhys Best

		 	Rhys Best
		 	Chairman of the Board of Directors of MRC Global Inc.


  

			
	EXECUTIVE
	
	 /s/ Robert J. Saltiel, Jr.

	Robert J. Saltiel, Jr.


  

  
 17 













 Exhibit A 

Release 
  

	1.	 In consideration of the payments and benefits to be made under the Employment Agreement, effective as of
March 15, 2021 (the “Employment Agreement”), to which Robert J. Saltiel, Jr. (the “Executive”) and MRC Global, Inc. (the “Company”) (each of the Executive and the Company, a
“Party” and collectively, the “Parties”) are parties, the sufficiency of which the Executive acknowledges, the Executive, with the intention of binding himself and his heirs, executors, administrators and assigns,
does hereby release, remise, acquit and forever discharge the Company and each of its subsidiaries and affiliates (the “Company Affiliated Group”), their present and former officers, directors, executives, shareholders, agents,
attorneys, employees and employee benefit plans (and the fiduciaries thereof), and the successors, predecessors and assigns of each of the foregoing (collectively, the “Company Released Parties”), of and from any and all claims,
actions, causes of action, complaints, charges, demands, rights, damages, debts, sums of money, accounts, financial obligations, suits, expenses, attorneys’ fees and liabilities of whatever kind or nature in law, equity or otherwise, whether
accrued, absolute, contingent, unliquidated or otherwise and whether now known or unknown, suspected or unsuspected, which the Executive, individually or as a member of a class, now has, owns or holds, or has at any time heretofore had, owned or
held, arising on or prior to the date hereof, against any Company Released Party that arises out of or relates to, the Employment Agreement, the Executive’s employment with the Company or any of its subsidiaries and affiliates, or any
termination of such employment, including claims 


  

	 	(i)	 for severance or vacation benefits, unpaid wages, salary or incentive payments, 



 

	 	(ii)	 for breach of contract, wrongful discharge, impairment of economic opportunity, defamation, intentional
infliction of emotional harm or other tort, 


  

	 	(iii)	 for any violation of applicable state and local labor and employment laws (including, without limitation, all
laws concerning unlawful and unfair labor and employment practices) and 


  

	 	(iv)	 for employment discrimination under any applicable federal, state or local statute, provision, order or
regulation, and including, without limitation, any claim under Title VII of the Civil Rights Act of 1964 (“Title VII”), the Civil Rights Act of 1988, the Fair Labor Standards Act, the Americans with Disabilities Act
(“ADA”), the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), the Age Discrimination in Employment Act (“ADEA”), and any similar or analogous state statute, excepting only:



  

	 	1.1.	 rights of the Executive arising under, or preserved by, this Release or Section 3 of the Employment
Agreement; 


  

	 	1.2.	 the right of the Executive to receive COBRA continuation coverage in accordance with applicable law;
















	 	1.3.	 claims for benefits under any health, disability, retirement, life insurance or other similar employee benefit
plan (within the meaning of Section 3(3) of ERISA) of the Company Affiliated Group; and 


  

	 	1.4.	 rights to indemnification the Executive has or may have under the
by-laws or certificate of incorporation of any member of the Company Affiliated Group or as an insured under any director’s and officer’s liability insurance policy or other insurance policy of the
Company and its subsidiaries that benefits the Executive now or previously in force. 


  

	2.	 The Executive acknowledges and agrees that the release of claims set forth in this Release is not to be
construed in any way as an admission of any liability whatsoever by any Company Released Party, any such liability being expressly denied. 


  

	3.	 The release of claims set forth in this Release applies to any relief no matter how called, including, without
limitation, wages, back pay, front pay, compensatory damages, liquidated damages, punitive damages, damages for pain or suffering, costs, and attorneys’ fees and expenses. 



 

	4.	 The Executive specifically acknowledges that his acceptance of the terms of the release of claims set forth in
this Release is, among other things, a specific waiver of his rights, claims and causes of action under Title VII, ADEA, ADA and any state or local law or regulation in respect of discrimination of any kind; provided, that nothing in this
Release shall be deemed, nor does anything contained herein purport, to be a waiver of any right or claim or cause of action which by law the Executive is not permitted to waive. 



 

	5.	 As to rights, claims and causes of action arising under the ADEA, the Executive acknowledges that he has been
given but not utilized a period of 45 days to consider whether to execute this Release. If the Executive accepts the terms hereof and executes this Release, he may thereafter, for a period of seven days following (and not including) the date of
execution, revoke this Release as it relates to the release of claims arising under the ADEA. If no such revocation occurs, this Release shall become irrevocable in its entirety, and binding and enforceable against the Executive, on the day next
following the day on which the foregoing seven-day period has elapsed. If such a revocation occurs, the Executive shall irrevocably forfeit any right to payment of the Severance Payments (as defined in the
Employment Agreement) or payment or receipt of the other applicable benefits, but the remainder of the Employment Agreement shall continue in full force. 


  

	6.	 Other than as to rights, claims and causes of action arising under the ADEA, the release of claims set forth in
this Release shall be immediately effective upon execution by the Executive. 


  

	7.	 The Executive acknowledges and agrees that he has not, with respect to any transaction or state of facts
existing prior to the date hereof, filed any complaints, charges or lawsuits against any Company Released Party with any governmental agency, court or tribunal. 



 

	8.	 The Executive acknowledges that he has been advised to seek, and has had the opportunity to seek, the advice
and assistance of an attorney with regard to the release of claims set forth in this Release, and has been given a sufficient period within which to consider the release of claims set forth in this Release. 



  
 2 














	9.	 The Executive acknowledges that the release of claims set forth in this Release relates only to claims which
exist as of the date of this Release. 


  

	10.	 The Executive acknowledges that the Severance Payments, Change in Control Severance Payments, Medical
Continuation and extended vesting period of options, as applicable, he is receiving in connection with the release of claims set forth in this Release and his obligations under this Release are in addition to anything of value to which the Executive
is entitled from the Company and any of its affiliates. 


  

	11.	 Each provision of this Release is severable from this Release, and if one or more provisions hereof are
declared invalid, the remaining provisions shall nevertheless remain in full force and effect. If any provision of this Release is so broad, in scope, or duration or otherwise, as to be unenforceable, such provision shall be interpreted to be only
so broad as is enforceable. 


  

	12.	 This Release constitutes the complete agreement of the Parties in respect of the subject matter hereof and
shall supersede all prior agreements between the Parties in respect of the subject matter hereof except to the extent set forth in this Release or the Employment Agreement. 



 

	13.	 The failure to enforce at any time any of the provisions of this Release or to require at any time performance
by another party of any of the provisions hereof shall in no way be construed to be a waiver of such provisions or to affect the validity of this Release, or any part hereof, or the right of any party thereafter to enforce each and every such
provision in accordance with the terms of this Release. 


  

	14.	 This Release may be executed in several counterparts, each of which shall be deemed to be an original, but all
of which together shall constitute one and the same instrument. Signatures delivered by facsimile shall be deemed effective for all purposes. 


  

	15.	 This Release shall be binding upon any and all successors and assigns of the Executive and the Company.



  

	16.	 Except for issues or matters as to which federal law is applicable, this Release shall be governed by and
construed and enforced in accordance with the laws of the State of Texas without giving effect to the conflicts of law principles thereof. 



[Signature page follows] 

  
 3 













 IN WITNESS WHEREOF, this Release has been signed by or on behalf of the Executive as of
________________________________. 
  

	
	EXECUTIVE
	
	  
 Robert J. Saltiel, Jr.




  
 4 













 Exhibit B 

Existing Inventions 
 [None.]